Trader notes, earnings previews, Confluences, weekly digests and roundups — long-form analysis grounded in ORTEX short interest, options flow and analyst data.
All articles — 32438 total
CrowdStrike is now trading above every price target raised in the past month, with earnings two weeks out and the CEO still selling into the rally. The stock closed at $221.90, up 5% on the week and 18.5% over the past…
Kontoor Brands enters its September 2 earnings window with the stock absorbing its sharpest weekly decline in months — down 10.1% to $74.96 — while the Street maintains bullish targets that now sit nearly 28% above the…
Alcon delivered its Q2 results on August 11 and the market answered with its clearest vote of confidence in months — the stock surged 6.5% on the day and is now up nearly 7% on the week to CHF 61.06, reversing a…
KSPI enters the week with a clear tension: founder Vyacheslav Kim is selling stock into a 3.7% weekly gain while Susquehanna just lifted its price target — a divergence that is harder to ignore than most. The insider…
JMIA is caught in an uncomfortable convergence: short sellers are rebuilding positions at the fastest pace in months, the stock has shed 17% over the past month to $5.81, and today's earnings release lands with no…
TTAN enters its September 3 earnings with an interesting divergence: short sellers have been quietly trimming positions even as the stock rallies, while the CEO continues selling into strength. Short interest has…
TOST enters the post-earnings week with a striking divergence: the stock is up 19% over the past month and analysts are tripping over each other to lift targets, yet insiders are selling into every uptick and short…
Diversified Energy Company has turned the corner post-earnings — the stock is up 9.3% on the week to $14.65, and the short-side conviction that defined the pre-print setup is now running into a meaningful reassessment…
TME has delivered its earnings and the market's verdict was swift — shares fell nearly 12% on August 11 to close at $8.72, extending a weekly loss of 9.4% and erasing the recovery that had carried the stock above $9.50…
Options positioning on UPWK has flipped sharply after the August 10 earnings rout — and it's telling a surprisingly different story from the elevated short interest still sitting on the books. The clearest signal this…
Bloom Energy has given back ground since last week's note — the stock is off 7.4% this week to $211.21 — and the short-interest data is now telling a different story than it was a week ago. The clearest shift is in…
Nexxen International heads into the back half of August with fresh analyst momentum colliding against a pattern of persistent CFO selling — the central tension in this week's setup. The most concrete signal this week…
Liquidia Corporation enters the post-earnings window with bulls and bears sharply divided — analysts rushing to raise targets on one side, a cluster of insider selling on the other. The catalyst is this week's earnings…
CRNX has completed a remarkable repositioning since the Vertex Pharmaceuticals acquisition announcement: the short book that once represented nearly 13% of the free float has been cut to a fraction of its former size,…
XLC enters the week with a small wrinkle in its six-week bear-retreat narrative — short interest jumped 17% in a single session on August 11 — but the broader picture of easing pressure remains unchanged. That…
After last week's 10% surge through the $411 ceiling, Broadcom has stalled at $416 and the question has shifted from whether the breakout holds to whether the September 2 earnings print can validate it. The pullback is…
Hamilton Insurance Group reported Q2 results on August 7 and came out the other side essentially flat — but the more interesting shift is happening in how short sellers are repositioning around the print. Short…
Amerant Bancorp heads into the back half of August with a fresh analyst downgrade cutting across an otherwise strong month, a modest short-interest rebuild, and options traders edging more cautious than usual. The most…
MNPR enters its August 14 earnings release with one of the more interesting short-covering stories in small-cap biotech right now — a high-conviction short position dissolving rapidly as the NDA clock ticks louder. The…
SELLAS Life Sciences Group reported its Q2 results on August 12 with one of the most heavily contested short positions in small-cap biotech still intact — and the data since the print shows bears have not…
